Drug interactions
Insulin aspart + Pioglitazone
Severity: Major
Insulin aspart and Pioglitazone: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Pioglitazone and insulin together increase the risk of fluid retention, edema and heart failure, and their glucose-lowering effects are additive, raising hypoglycemia risk. The combination is used but requires attention in patients with cardiac disease.
What this interaction means in plain words
Insulin aspart and Pioglitazone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Insulin aspart belongs to Endocrine; Pioglitazone belongs to Endocrine.
Why it happens
Pioglitazone PPAR-gamma activation promotes renal sodium and fluid retention, compounded by insulin's sodium-retaining effect, plus additive glucose lowering.
What to do
Monitor for weight gain, edema and heart failure symptoms, and avoid in patients with NYHA class III-IV heart failure. Reduce the insulin dose if hypoglycemia occurs.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Insulin aspart and Pioglitazone, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Insulin aspart
Other interactions of Pioglitazone
Frequently asked questions
Can I take Insulin aspart with Pioglitazone?
MediHelp rates the interaction as major. Insulin aspart and Pioglitazone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Pioglitazone and insulin together increase the risk of fluid retention, edema and heart failure, and their glucose-lowering effects are additive, raising hypoglycemia risk. The combination is used but requires attention in patients with cardiac disease.
How serious is the interaction between Insulin aspart and Pioglitazone?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for weight gain, edema and heart failure symptoms, and avoid in patients with NYHA class III-IV heart failure. Reduce the insulin dose if hypoglycemia occurs.
What other medicines interact with Insulin aspart?
MediHelp also lists interactions of Insulin aspart with, for example, Alogliptin-pioglitazone, Ethanol, Glimepiride-pioglitazone. The full list is on the Insulin aspart page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
